Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
BACKGROUND: RTS,S/AS01(E) is the lead candidate malaria vaccine and confers pre-erythrocytic immunity. Vaccination may therefore impact acquired immunity to blood-stage malaria parasites after natural infection. METHODS: We measured, by enzyme-linked immunosorbent assay, antibodies to 4 Plasmodium...
Main Authors: | Bejon, P, Cook, J, Bergmann-Leitner, E, Olotu, A, Lusingu, J, Mwacharo, J, Vekemans, J, Njuguna, P, Leach, A, Lievens, M, Dutta, S, von Seidlein, L, Savarese, B, Villafana, T, Lemnge, M, Cohen, J, Marsh, K, Corran, P, Angov, E, Riley, E, Drakeley, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
by: Bejon, P, et al.
Published: (2008) -
Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
by: Horowitz, A, et al.
Published: (2012) -
Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
by: Olotu, A, et al.
Published: (2011) -
Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
by: Lusingu, J, et al.
Published: (2010) -
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
by: Bejon, P, et al.
Published: (2008)